Daniela Travaglini
San Pio Hospital Via De Lellis
Vasto, 66054, Italy
Vasto, 66054, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Hyperkinetic manifestations in sporadic parkinsonism: An exploratory case series with APOE and NOS3 variants.
Journal: Clinical parkinsonism & related disorders
Published: March 23, 2026
Anti-RI-associated paraneoplastic syndrome in breast cancer and multiple sclerosis: an unusual comorbidity.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: July 18, 2025
Sporadic hemiplegic migraine with novel missense mutation in the SCN1A gene and positive response to anti-CGRP antibody: a case report.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: January 18, 2024
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: November 02, 2021
New daily persistent headache after SARS-CoV-2 infection: a report of two cases.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: April 18, 2021
Data of safety in a single-center alemtuzumab treated population.
Journal: Data in brief
Published: November 29, 2019
Alemtuzumab treatment of multiple sclerosis in real-world clinical practice: A report from a single Italian center.
Journal: Multiple sclerosis and related disorders
Published: April 02, 2019
Simultaneous early-onset severe autoimmune hemolytic anemia and albuminuria during alemtuzumab treatment for multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: January 24, 2018
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy.
Journal: International journal of immunopathology and pharmacology
Published: July 10, 2014
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Journal: Neuropsychiatric disease and treatment
Published: July 10, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026